The pathophysiology of T2DM encompasses a network of molecular disturbances, including dysregulated glucose metabolism, heightened oxidative stress, and impaired insulin signaling (Galicia-Garcia et al., 2020; Mlynarska et al., 2025). This evidence concerns the gene INS and type 2 diabetes mellitus.